Arcus Biosciences (RCUS) Cash from Investing Activities Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | 256.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256.25% |
| Dec 31, 2025 | -456.86% |
| Sep 30, 2025 | 372.41% |
| Jun 30, 2025 | 117.46% |
| Mar 31, 2025 | 118.93% |
| Dec 31, 2024 | 82.14% |
| Sep 30, 2024 | -363.64% |
| Jun 30, 2024 | 142.31% |
| Mar 31, 2024 | -231.01% |
| Dec 31, 2023 | -40.43% |
| Sep 30, 2023 | -52.17% |
| Jun 30, 2023 | 112.09% |
| Mar 31, 2023 | 148.13% |
| Dec 31, 2022 | 150.24% |
| Sep 30, 2022 | 125.96% |
| Jun 30, 2022 | -7,259.51% |
| Mar 31, 2022 | -526.57% |
| Dec 31, 2021 | 13,710.29% |
| Sep 30, 2021 | 77.11% |
| Jun 30, 2021 | 103.45% |